FDA takes action against benzocaine in the US

24 May 2018 - Deborah Wilkes

Archived

The US Food and Drug Administration (FDA) is urging consumers not to use OTC teething products containing benzocaine because they "pose a serious risk" to infants and children younger than two years.

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: